Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States
Journal of the American Heart Association · 2023
DOI: 10.1161/jaha.123.030766 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Juliana Nga Man Lui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Failure, Myocardial Infarction, Stroke. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Background
Despite optimized risk factor control, people with prior cardiovascular disease remain at high cardiovascular disease risk. We assess the immediate‐ and longer‐term impacts of new vascular and nonvascular events on quality of life (QoL) and hospital costs among participants in the REVEAL (Randomized Evaluation of the Effects of Anacetrapib Through Lipid Modification) trial in secondary prevention. Methods and Results Data on demographic and clinical characteristics, health‐related quality of life (QoL: EuroQoL 5‐Dimension‐5‐Level), adverse events, and hospital admissions during the 4‐year follow‐up of the 21 820 participants recruited in Europe and North America informed assessments of the impacts of new adverse events on QoL and hospital costs from the UK and US health systems' perspectives using generalized linear regression models. Reductions in QoL were estimated in the years of event occurrence for nonhemorrhagic stroke (−0.067 [United Kingdom], −0.069 [US]), heart failure admission (−0.072 [United Kingdom], −0.103 [US]), incident cancer (−0.064 [United Kingdom], −0.068 [US]), and noncoronary revascularization (−0.071 [United Kingdom], −0.061 [US]), as well as in subsequent years following these events. Myocardial infarction and coronary revascularization (CRV) procedures were not found to affect QoL. All adverse events were associated with additional hospital costs in the years of events and in subsequent years, with the highest additional costs in the years of noncoronary revascularization (£5830 [United Kingdom], $14 133 [US Medicare]), of myocardial infarction with urgent CRV procedure (£5614, $24722), and of urgent/nonurgent CRV procedure without myocardial infarction (£4674/£4651 and $15 251/$17 539).
Conclusions
Stroke, heart failure, and noncoronary revascularization procedures substantially reduce QoL, and all cardiovascular disease events increase hospital costs. These estimates are useful in informing cost‐effectiveness of interventions to reduce cardiovascular disease risk in secondary prevention. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01252953; https://www.Isrctn.com . Unique identifier: ISRCTN48678192; https://www.clinicaltrialsregister.eu . Unique identifier: 2010‐023467‐18.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom.
- Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom.
- Medical Research Council Population Health Research Unit, Nuffield Department of Population Health University of Oxford United Kingdom.
- Health Economics and Policy Research Unit, Wolfson Institute of Population Health Queen Mary University of London United Kingdom.
ORCID-Profile: Juliana Nga Man Lui, Jemma C Hopewell, Fang Chen, Alastair Gray, Borislava Mihaylova
Förderung
- British Heart Foundation
Zitieren
APA
Lui, J. N. M., Williams, C., Keng, M. J., Hopewell, J. C., Sammons, E., Chen, F., Gray, A., Bowman, L., Landray, S. M. J., Mihaylova, B., & REVEAL Collaborative Group (2023). Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.030766
Vancouver
Lui JNM, Williams C, Keng MJ, Hopewell JC, Sammons E, Chen F, et al. Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States. Journal of the American Heart Association. 2023. doi:10.1161/jaha.123.030766
BibTeX
@article{Lui2023,
author = {Lui, Juliana Nga Man and Williams, Claire and Keng, Mi Jun and Hopewell, Jemma C and Sammons, Emily and Chen, Fang and Gray, Alastair and Bowman, Louise and Landray, Sir Martin J and Mihaylova, Borislava and REVEAL Collaborative Group, REVEAL Collaborative Group},
title = {Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States},
journal = {Journal of the American Heart Association},
year = {2023},
doi = {10.1161/jaha.123.030766}
}
EUVIMED